Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from ‘excess’ ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...

FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000% CVS responds by saying regulator’s latest report is ‘inappropriate and misleading’ Published: Jan. 14, 2025 at ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

The Federal Trade Commission said in its second interim staff report on prescription-drug middlemen that the "significant markups" in prices above what the drugs cost generated an extra $7.3 billion ...

The City of Columbus filed a lawsuit against several drug companies that artificially raised prices on insulin prices for ...

The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

On the post-earnings call with analysts, Chief Executive Andrew Witty addressed the recent public backlash over high drug costs and transparency of coverage, particularly following killing of Brian ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...

According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...